EGFR and prostate cancer: These pathways and processes seemed to be characteristic for prostate cancer initiation and progression and could be assigned to three main biological processes, including cholesterol biosynthesis, epithelial-to-mesenchymal transition (EMT) involving epidermal growth factor receptor (EGFR) signaling, and an increased metabolic activity.